Related Experiment Video

Updated: Sep 20, 2025

Location, Dissection, and Analysis of the Murine Stellate Ganglion
07:50

Location, Dissection, and Analysis of the Murine Stellate Ganglion

Published on: December 22, 2020

10.9K

Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs

John Larson1, Lucas Rich1, Amrish Deshmukh2

  • 1Division of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

Journal of Clinical Medicine
|June 10, 2022
PubMed

Insights

Ventricular arrhythmias (VAs) are a serious heart condition. Anti-arrhythmic drugs (AADs) and beta blockers are key treatments, especially for VAs linked to heart disease or specific syndromes, helping prevent sudden cardiac death.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Ventricular arrhythmias (VAs) are a significant cause of sudden cardiac death (SCD).
  • Management focus has shifted to reducing morbidity from VAs and implantable cardiac defibrillator (ICD) therapies.
  • Anti-arrhythmic drugs (AADs) are crucial for managing recurrent VAs.

Purpose of the Study:

  • To review the current role of AADs in managing VAs.
  • To highlight the importance of amiodarone and beta blockers in specific patient populations.
  • To identify areas for future research in VA pharmacotherapy.

Main Methods:

  • Literature review of current guidelines and clinical trials.
  • Analysis of pharmacologic therapies for VAs in structural heart disease.
  • Evaluation of AADs for VAs in structurally normal hearts.

Main Results:

  • Amiodarone is the guideline-directed therapy for VAs secondary to structural heart disease.
  • Beta blockers are underutilized but evidence-supported adjuncts for VA management.
  • AADs offer tailored therapies for VAs in patients with defined syndromes.

Conclusions:

  • AADs remain vital for VA treatment, with amiodarone and beta blockers playing key roles.
  • Further research is needed for newer AADs and direct comparisons of existing therapies.
  • Optimizing pharmacologic management can improve outcomes and quality of life for VA patients.

Keywords:
anti-arrhythmic drugselectrical stormventricular arrhythmiasventricular fibrillationventricular tachycardia

More Related Videos

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice06:07

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

3.9K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

969

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
115
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.8K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
917
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.3K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
177